NCT07072117View on ClinicalTrials.gov

Intranasal Dexmedetomidine, Ketamine or Midazolam for Anxiety and Respiratory Complications in Children

NACompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

August 20, 2023

Study Completion Date

October 31, 2023

Conditions
Adenotonsillectomy
Interventions
DRUG

Intranasal Dexmedetomidine as a Premedication for Prevention of Anxiety & Respiratory Complications

Intranasal Dexmedetomidine as a Premedication for Prevention of Anxiety and Respiratory Complications in Children Undergoing Adenotonsillectomy

DRUG

Intranasal Ketamine as a Premedication for Prevention of Anxiety and Respiratory Complications

Intranasal Ketamine as a Premedication for Prevention of Anxiety and Respiratory Complications in Children Undergoing Adenotonsillectomy

DRUG

Intranasal Midazolam as a Premedication for Prevention of Anxiety and Respiratory Complications

Intranasal Midazolam as a Premedication for Prevention of Anxiety and Respiratory Complications in Children Undergoing Adenotonsillectomy

Trial Locations (1)

Unknown

Faculty of Medicine - Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV